Dokument: Pectoral muscle mass is not a robust prognostic factor for survival after left ventricular assist device (LVAD) implantation

Titel:Pectoral muscle mass is not a robust prognostic factor for survival after left ventricular assist device (LVAD) implantation
URL für Lesezeichen:https://docserv.uni-duesseldorf.de/servlets/DocumentServlet?id=67726
URN (NBN):urn:nbn:de:hbz:061-20241127-110744-5
Kollektion:Publikationen
Sprache:Englisch
Dokumententyp:Wissenschaftliche Texte » Artikel, Aufsatz
Medientyp:Text
Autoren: Jenkins, Freya Sophie [Autor]
Minol, Jan-Philipp [Autor]
Akar, Tarik [Autor]
Yilmaz, Esma [Autor]
Immohr, Moritz Benjamin [Autor]
Dalyanoglu, Ismail [Autor]
Korbmacher, Bernhard [Autor]
Aissa, Joel [Autor]
Boeken, Udo [Autor]
Lichtenberg, Artur [Autor]
Dateien:
[Dateien anzeigen]Adobe PDF
[Details]1,29 MB in einer Datei
[ZIP-Datei erzeugen]
Dateien vom 27.11.2024 / geändert 27.11.2024
Stichwörter:Left ventricular heart failure, Pectoral muscle mass, Left ventricular assist device, Frailty
Beschreibung:Background

Left ventricular assist devices (LVAD) are an established treatment for end-stage left ventricular heart failure. Parameters are needed to identify the most appropriate patients for LVADs. This study aimed to evaluate pectoral muscle mass and density as prognostic parameters.
Methods

This single-center study included all patients with LVAD implantation between January 2010 and October 2017 and a preoperative chest CT scan. Pectoral muscle mass was assessed using the Pectoralis Muscle Index (PMI, surface area indexed to height, cm2/m2) and pectoral muscle density by Hounsfield Units (HU). Overall mortality was analyzed with Kaplan–Meier survival analysis and 1-year and 3-year mortality with receiver operating characteristic (ROC) curves and Cox regression models.
Results

57 patients (89.5% male, mean age 57.8 years) were included. 64.9% of patients had end-stage left ventricular failure due to ischemic heart disease and 35.1% due to dilated cardiomyopathy. 49.2% of patients had preoperative INTERMACS profile of 1 or 2 and 33.3% received mechanical circulatory support prior to LVAD implantation. Total mean PMI was 4.7 cm2/m2 (± 1.6), overall HU of the major pectoral muscle was 39.0 (± 14.9) and of the minor pectoral muscle 37.1 (± 16.6). Mean follow-up was 2.8 years (± 0.2). Mortality rates were 37.5% at 1 year and 48.0% at 3 years. Neither PMI nor HU were significantly associated with overall mortality at 1-year or 3-year.
Conclusions

The results of our study do not confirm the association between higher pectoral muscle mass and better survival after LVAD implantation previously described in the literature.
Rechtliche Vermerke:Originalveröffentlichung:
Jenkins, F. S., Minol, J.-P., Akar, T., Yilmaz, E., Immohr, M. B., Dalyanoglu, I., Korbmacher, B., Aissa, J., Boeken, U., Lichtenberg , A., Akhyari, P., & Hannan, D. (2024). Pectoral muscle mass is not a robust prognostic factor for survival after left ventricular assist device (LVAD) implantation. Journal of Cardiothoracic Surgery, 19, Article 76. https://doi.org/10.1186/s13019-024-02547-8
Lizenz:Creative Commons Lizenzvertrag
Dieses Werk ist lizenziert unter einer Creative Commons Namensnennung 4.0 International Lizenz
Fachbereich / Einrichtung:Medizinische Fakultät
Dokument erstellt am:27.11.2024
Dateien geändert am:27.11.2024
english
Benutzer
Status: Gast
Aktionen